Form 4: ANI Pharmaceuticals SVP & CFO Stephen Carey Reports Stock Transactions

Stephen Carey, SVP & CFO of ANI Pharmaceuticals, reported the disposition of shares to cover tax obligations and sales of common stock.

Summary

• Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reported changes in beneficial ownership of the company's stock.
• On March 7, 2024, 4,216 shares were disposed of to cover tax obligations at a price of $66.71 per share.
• On March 11, 2024, 7,787 shares were sold at a weighted average price of $65.55, with individual sales ranging from $65.08 to $66.63.
• Following these transactions, Carey directly owns 177,712 shares of ANI Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, depending on the overall market perception of the company and the reasons behind the sale.

Key Dates